# An Integrative Study of the Role of Microbiome, Metabolome, Transcriptome and Chronobiology in the Context of Type 2 Diabetes.

> **NCT06783218** · — · COMPLETED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 36 (actual)

## Conditions studied

- Prediabetes / Type 2 Diabetes
- Obesity and Overweight
- Insulin Resistance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06783218
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-21
- **Primary completion:** 2024-10-15
- **Final completion:** 2024-10-28
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06783218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06783218, "An Integrative Study of the Role of Microbiome, Metabolome, Transcriptome and Chronobiology in the Context of Type 2 Diabetes.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06783218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*